Navigation Links
net in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...egy and as a result reported $669,000 of pro forma net income for the quarter ended June 30, 2009, a sign...ame period in 2008. Isis also reported a pro forma net operating loss of $1.3 million for the second quarter compared to pro forma net operating income of $4.6 million for the same peri...

NewCardio Announces Master Services Agreement With Dedicated Phase I

...provide. In addition, we can reduce study timelines by several weeks, providing significant savings to customers on the overall cost of the study. The net result is that sponsors will receive higher quality study results and also save time and money. This is a win-win for Dedicated Phase I and our custom...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...or the second quarter ended June 30, 2009. net loss for the quarter ended June 30, 2009 was $32.1 million or $0.35 per share, compared to net loss of $33.4 million or $0.36 per share in the se...29) (6,285) (7,847) Other income, net 203 769 248 1,071 ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

...sitions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&...

New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed

...uman and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research ...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

..., product development and business strategy, as well as estimates of future net sales, future expenses, future net income and future earnings per share. Statements including words such as "...

New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%

...y triglycerides and promotes digestive health," says Chronister. "This latest study strongly suggests that a very potent overall health benefit is the net result of adding prebiotics to the diet." A precis of the research is presented at http://www.prebiotin.com , as well as a link to the full ...

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

...the collaboration Shire will pay development and sales milestones up to a maximum of $390 million, and will also pay tiered, double digit royalties on net sales of the products. Shire also shares world-wide development costs on a 50/50 basis, and in return Shire received rights to commercialize these pro...

VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers

...wear the garment. Numerous studies confirm the potential of RPM initiatives to improve outcomes for patients with chronic diseases and reduce the net cost of their care. It is estimated that savings resulting from RPM will reach $200 billion over the next 25 years in the United States alone(1). Howe...

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

...sitions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&...

Boehringer Ingelheim Unveils Diabetes Pipeline

...or human and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

...s on sales elsewhere in the world. If Celtic Pharma sells or licenses the commercialization rights to XERECEPT, NTI is entitled to a percentage of the net proceeds received by Celtic. NTI has not reviewed the data from the clinical trials or the preclinical studies and cannot independently corrobora...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

...atment-naive, had locally inoperable or metastatic net with the primary tumor located in the midgut, were... in the endocrine and nervous systems. While these net are often slow-growing, when the tumor is inoperable patients with advanced net have limited treatment options(2). The safety...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

...percent lower than CABG at one year (8,295 pounds Sterling PCI vs. 11,101 pounds Sterling CABG, p<0.001). The lower medical costs coupled with the net improvement in quality of life resulted in PCI as the dominant treatment strategy at one year. Results further showed that although the average ...

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

... exceeds $350,000. In addition to the purchase price payable at closing, Pierrel will pay Encorium a 10% commission on the value of any new contract, net of pass-through costs, executed after the closing date but prior to December 31, 2009, which constitute part of the Company's pipeline at closing. ...

DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms

...on and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents....

Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009

...or human and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of $17 billion (11.6 billion euro) while spending one-fifth of net sales in its largest business segment, Prescription Medicines, on research ...

Spherix Reports First Quarter 2009 Earnings

... the first quarters ended 2009 and 2008. The net loss for the quarter ended March 31, 2009 was $2.0 million or $0.14 per share, compared with a net loss of $1.9 million or $0.13 per share for the sa... --- --- net loss $(2,066,084...

BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

...ses in professional fees and operating costs. net loss for the quarter ended March 31, 2009, was $9.3 million, or $0.24 per share, compared to a net loss for the quarter ended March 31, 2008, of $13....llion. BioCryst continues to expect the Company's net cash use in 2009 will be between $30.0 and $38.0 m...

Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery

...artis is the only company with leading positions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland,...

Bionovo Announces First Quarter 2009 Highlights and Financial Results

...in the second quarter. The Company reported a net loss for the three months ended March 31, 2009 of $4.7 million, or $0.06 per share, compared with a net loss of $3.9 million, or $0.05 per share, for the ... (79) (19) (156) net loss $(4,668) $(3,94...

Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status

...provided an update on its product candidates. The net loss for the quarter, as reported in accordance wi...ited States (GAAP), was $6.9 million compared to a net loss of $18.4 million in the comparable period in ...educe its expenses by approximately $21.5 million, net of severance costs, for fiscal year 2009, compared...

InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients

... minimizing arterial injury, this promising technology can be an effective and uniform drug delivery mechanism with the help of the novel micron-level net for next generation drug eluting stents. InspireMD intends to pursue applications of this technology both for bare metal and drug eluting stents in co...

Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update

...ed Financial Results The Company reported a net loss of $13.0 million ($0.38 diluted loss per shar...r the quarter ended March 31, 2009 compared with a net loss of $9.9 million ($0.29 diluted loss per share... ------- ------- Other income (expense), net (706) 664 ...

New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting

...or human and veterinary medicine. In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research ...

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

...t in part by associated severance costs. net Loss Attributable to Lexicon Pharmaceuticals, Inc.: net loss for the three months ended March 31, 2009 was $21.6 million, or $0.16 per share, compared to a net loss of $18.0 million, or $0.13 per share, in the ...

SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production

...nes. Vivalis receives up front, milestones, and royalties on its licensees' net sales. 2. The development of production systems for recombinant protei...ies. Vivalis receives up front, milestones, and royalties on its licensees' net sales. 3. The construction of a portfolio of proprietary products in t...

Prometheus and Rosetta Genomics Announce License and Collaboration Agreement

...rms of the license agreement provide for payments to Rosetta, either as milestones or research and development funding, as well as royalty payments on net sales in the U.S. Under the terms of a separate stock purchase agreement, Prometheus will also make an equity investment in Rosetta of $8 million at $...

MedNet Solutions Certified to Score SF-12v2 Health Survey

...., PhD is a thought-leader in the field of psychometrics and health outcome measurement. Visit us at www.qualitymetric.com . Abo u t Me d net Solution s : MedNet Solutions is a global healthcare technology company specializing in clinical study management systems designed for the global...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

...sitions in these areas. In 2008, the Group's continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease

...xity, PCI was favored, providing more quality-adjusted life years and lower net medical costs than CABG. For patients with the most complex disease -- and...lightly more quality-adjusted life years, with no significant difference in net medical costs at one year. The results showed that both PCI and CABG...

A Joint Statement From America's Prostate Cancer Advocacy, Education, and Support Organizations

...rg * Prostate Health Education Network - www.prostatehealthed.org * The Prostate Cancer Mission - www.pcmission.org * The Prostate net - www.prostatenet.org * Us TOO International Prostate Cancer Education and Support Network - www.ustoo.com * Virginia Prostate Cancer Co...

InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation

... aiding collaboration and the spread of knowledge. For large global challenges like infectious diseases and climate change, it makes sense to cast the net as wide as possible to find experts who can solve a problem," said Steven Inchcoombe, Managing Director, Nature Publishing Group. "Through this partne...

XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

...n its sole discretion, issue additional ordinary shares to Bio-GAL Ltd in lieu of such milestone payment. XTL is also obligated to pay 1% royalties on net sales of the product. The closing of the transaction is subject to various conditions including XTL's and Bio-GAL's shareholders' approvals, as well ...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

... drew down approximately $20 million of additional net cash proceeds under the Company's amended and rest...r 2008 Financial Results The Company reported a net loss of $13.9 million ($0.41 diluted loss per shar...on) for the fourth quarter of 2008 compared with a net loss of $9.6 million ($0.28 diluted loss per share...

Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients

...lth economic analysis of the Swedish study has also been published and concluded that routine prophylactic use of the Gentamicin Implant resulted in a net cost saving per patient. Patient enrolment in a second phase 3 trial being conducted in patients undergoing open colorectal surgery is expected t...

DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology

...on and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents....

Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

...B agreement with GSK. The Company reported a net loss for 2008 of $244.9 million ($1.81 per share), compared with a net loss of $262.4 million ($1.95 per share) for 2007. The decreased net loss for 2008 was due primarily to a gain on the s...

From eResearchTechnology to ERT

... to 2008 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, inte...

Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

...evelopment and commercialization of potential products resulting from this collaboration, as well as undisclosed royalties on the associated worldwide net sales. Ambrx also retains the option to convert its right to receive royalties in the U.S. to a profit and loss sharing option. If the option is exerc...
Other Tags
(Date:8/20/2014)... -- The second annual Biometrics UnPlugged Executive Summit, set ... on September 15, 2014, will feature ... Strategy at Samsung, and Philippe de Raet, Vice President, ... year,s event is Mobility at the Crossroads of ... Mobility at the Crossroads of Commerce & Privacy ...
(Date:8/19/2014)... release is available in German . ... inherently intermittent energy sources. If a large amount of electricity ... future, excess energy will have to be stored during productive ... existing storage capacities are far from adequate for the purpose. ... One important focus lies on battery systems that used to ...
(Date:8/19/2014)... retail seafood counters in 10 different states show ... to unexpectedly high levels of mercury, a harmful ... fish of the same species, but from a ... according to new research by University of Hawai,i ... is essential to allow consumers to choose sustainable ...
Breaking Biology News(10 mins):Biometrics UnPlugged: Mobility at the Crossroads of Commerce & Privacy to Feature Interactive Sessions with Samsung and Experian 2Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3
(Date:8/20/2014)... have found a novel approach to treating cancer - ... edition of Science Translational Medicine shows that ... sent by nerves that are linked to cancer stem ... of Botox made the treatment cheap, safe and efficient. ... mice, and will soon start testing on humans. , ...
(Date:8/20/2014)... 2014 Quincy Bioscience, a Wisconsin-based biotech ... of the fastest growing private companies in the ... No. 2,941, Quincy Bioscience is honored again to be ... States. , Quincy Bioscience is manufacturer of Prevagen brand ... protein originally discovered in jellyfish and clinically shown to ...
(Date:8/20/2014)... DALLAS (PRWEB) August 20, 2014 Caddis ... track records of any healthcare real estate company in ... of medical assets valued at $500 million, including more ... of that significant growth, including expansions into new geographic ... expanded capabilities, company executives are pleased to announce an ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Braverman Eye ... the help of their experienced surgeons trained in PresbyLasik. ... to regain their lost or inaccurate vision. Their diligent ... Lasik surgery is making it possible for Presbyopia patients ... which occurs normally in people in the age group ...
(Date:8/20/2014)... August 20, 2014 Texas Medical Research Associates ... The study will help test the effectiveness of a new ... high cholesterol may be eligible to participate in the study. ... in the blood can lead to cardiovascular disease, the no. ... can help reduce the risk of heart disease and stroke. ...
Breaking Medicine News(10 mins):Health News:Treating gastric cancer -- with Botox 2Health News:Quincy Bioscience Recognized in Inc. 500|5000 List of America’s Fastest Growing Companies for Third Consecutive Year 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Braverman Eye Center Now Offers Multifocal PresbyLasik in Florida by Trained Surgeons 2Health News:Texas Medical Research Associates Announce New Study 2
Other Contents